Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus.
Alexander TobiasLennard OstendorfRobert BiesenUdo SchneiderGerd-Rüdiger R BurmesterFalk HiepePublished in: Annals of the rheumatic diseases (2023)